These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24379270)

  • 1. [Resistance of Pseudomonas aeruginosa to antibiotics].
    Wolska K; Kot B; Piechota M; Frankowska A
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1300-11. PubMed ID: 24379270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Previous Antibiotic Exposure and Antimicrobial Resistance Patterns of
    Djordjevic ZM; Folic MM; Jankovic SM
    Balkan Med J; 2017 Dec; 34(6):527-533. PubMed ID: 29215335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections.
    Van Eldere J
    J Antimicrob Chemother; 2003 Feb; 51(2):347-52. PubMed ID: 12562701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The peculiarities of Pseudomonas aeruginosa resistance to antibiotics and prevalence of serogroups.
    Gailiene G; Pavilonis A; Kareiviene V
    Medicina (Kaunas); 2007; 43(1):36-42. PubMed ID: 17297282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of antibiotic resistance in Pseudomonas aeruginosa. Implications for empiric and definitive therapy.
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():8-12. PubMed ID: 28882007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current microbiological problems. Antibiotic resistance and therapeutic problems raised by Pseudomonas aeruginosa].
    Bert F; Lambert-Zechovsky N
    Presse Med; 1999 Feb; 28(8):451-8. PubMed ID: 10093607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro interaction of various antibiotic combinations recommended by Chinese consensus statement against carbapenems-resistant Pseudomonas aeruginosa.
    Ma W; Li J; Wang D; Yu C; Sun S
    Lett Appl Microbiol; 2019 Sep; 69(3):198-203. PubMed ID: 31236975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of the frequency of PER-1 type beta-lactamase and antimicrobial resistance rates in nosocomial isolates of Pseudomonas aeruginosa].
    Atilla A; Eroğlu C; Esen S; Sünbül M; Leblebicioğlu H
    Mikrobiyol Bul; 2012 Jan; 46(1):1-8. PubMed ID: 22399165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.
    El Zowalaty ME; Al Thani AA; Webster TJ; El Zowalaty AE; Schweizer HP; Nasrallah GK; Marei HE; Ashour HM
    Future Microbiol; 2015; 10(10):1683-706. PubMed ID: 26439366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen burden & associated antibiogram of
    Kumari M; Khurana S; Bhardwaj N; Malhotra R; Mathur P
    Indian J Med Res; 2019 Feb; 149(2):295-298. PubMed ID: 31219098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa susceptibility in a university hospital: recognition and treatment.
    Rotschafer JC; Shikuma LR
    Drug Intell Clin Pharm; 1986; 20(7-8):575-81. PubMed ID: 3091346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():17-32. PubMed ID: 15953020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of a program to reduce hospital ciprofloxacin use on nosocomial Pseudomonas aeruginosa susceptibility to quinolones and other antimicrobial agents.
    Cook PP; Das TD; Gooch M; Catrou PG
    Infect Control Hosp Epidemiol; 2008 Aug; 29(8):716-22. PubMed ID: 18590455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa.
    Cardozo C; Rico V; Agüero D; Soriano A
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):32-34. PubMed ID: 31475807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance.
    Hauser AR; Sriram P
    Postgrad Med; 2005 Jan; 117(1):41-8. PubMed ID: 15672890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in antibiotic resistance level of nosocomial Pseudomonas aeruginosa isolates in the largest university hospital of Lithuania.
    Adukauskienė D; Vitkauskaitė A; Skrodenienė E; Dambrauskienė A; Vitkauskienė A
    Medicina (Kaunas); 2011; 47(5):278-83. PubMed ID: 21956136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.